Counselors in Windsor, VA Accepting Medicare
4 Counselors found. Showing 1 - 4
 Dr. Tiffany Chanell Duck, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 11339 Windsor Blvd, Windsor, VA 23487 Phone: 757-371-5495 |
Ms. Mariellen E Blanton, LCSW Counselor - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 79 E Windsor Blvd, Windsor, VA 23487 Phone: 757-242-9988 Fax: 757-242-3647 |
 Mr. Jorge Eduardo Grandela, MA/PSYD Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 79 E. Windsor Blvd, Windsor, VA 23487 Phone: 757-242-9988 |
Ms. Lorrie Saunders Gaskins, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 16022 Everets Rd, Windsor, VA 23487 Phone: 757-255-4616 Fax: 757-255-4628 |
News Archive
Study highlights experiences of addiction treatment professionals post-Hurricane Katrina
Ten years post-Hurricane Katrina, experts have reflected on the aftermath through the eyes of addiction treatment professionals to become better prepared for future tragedies.
Longer withdrawal times during colonoscopy correlates with higher rate of polyp detection
Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) researchers found that longer withdrawal times during a colonoscopy correlates with a higher rate of polyp detection. The study was recently published online in in the American Journal of Gastroenterology.
Reducing incorrect gene expression can extend lifespan of cells
Working with yeast and worms, researchers found that incorrect gene expression is a hallmark of aged cells and that reducing such "noise" extends lifespan in these organisms. The team published their findings this month in Genes & Development.
Takeda commences TAK-875 Phase 3 clinical trial program for type 2 diabetes
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiaries, Takeda Global Research & Development Center, Inc., and Takeda Global Research & Development Centre (Europe), Ltd., announced today the initiation of the Company's Phase 3 clinical trial program for TAK-875, an investigational therapy for type 2 diabetes.
Increasing levels of GGA3 protein prevent accumulation of enzyme linked to Alzheimer's disease
Researchers at Tufts University School of Medicine have zeroed in on a protein that may play a role in the progression of Alzheimer's disease. The team found that increasing levels of the protein (called GGA3) prevented the accumulation of an enzyme linked to Alzheimer's. The strategy may lead to new treatments for the neurodegenerative disease.
› Verified 4 days ago